ECONTRA ONE-STEP
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 03 Feb 2025)
What this means for you
Registered since 10 Sept 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Sept 2029: the §8 & §9 renewal).
Record
- Serial number
- 87804364
- Registration number
- 5858228
- Mark type
- Word mark
- Filed
- 20 Feb 2018
- Published for opposition
- 21 Aug 2018
- Registered
- 10 Sept 2019
- Next maintenance filing
- §8 & §9 renewal, due by 10 Sept 2029 (grace period to 10 Mar 2030)
- Attorney of record
- Glenn K. Robbins II
Goods and services
- Class 005 — Pharmaceuticals: Contraceptive preparations; oral contraceptives
Owner
- Afaxys, Inc., Charleston, SC, US
- Afaxys, Inc., Charleston, SC, US
- Afaxys, Inc., Charleston, SC, US
Prior registrations
Board proceedings on this mark
- Extension of Time to Oppose No. 87804364 — Foundation Consumer Healthcare, LLC v. Afaxys, Inc., filed 18 Sept 2018 (Terminated)
Prosecution history
- 03 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 10 Sept 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Sept 2019 — REGISTERED-PRINCIPAL REGISTER
- 06 Aug 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Aug 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Jul 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Jun 2019 — USE AMENDMENT FILED
- 16 Jul 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Jun 2019 — TEAS STATEMENT OF USE RECEIVED
- 12 Feb 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Dec 2018 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 24 Oct 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED